JBC Impact Factor

Data sourced from our analysis of 20,449 journals in the Clarivate 2026 JCR release database.

JBC's IF (4.1) is lower than Molecular Cell (16) or EMBO Journal (8.4), but the comparison is misleading. JBC publishes ~2,500 papers per year across all of biochemistry. Molecular Cell publishes ~200 highly selective papers. JBC's strength is its breadth and accessibility.

The five-year JIF (4.3) running above the two-year (4.1) shows JBC papers have lasting citation value. Biochemistry is a field where detailed mechanistic studies get cited as reference points for years.

For career purposes, JBC is universally recognized in biochemistry. It's not a prestige journal like Cell or Nature, but a strong JBC paper demonstrates rigorous biochemistry in the field's community journal.

JBC is known for relatively fast turnaround. The first editorial decision typically arrives within 30 days, which is faster than many comparable journals. If revisions are requested, the journal gives authors about 2 months to resubmit. Total time from submission to online publication is usually 4-6 months, which is competitive for the field.

JBC has been fully open access since January 2021. All published articles are freely available without a subscription. The APC is approximately $2,000-$2,500, which is lower than many comparable OA journals (for example, Nature Communications charges ~$7,350). ASBMB members receive a discount on the APC. The OA transition has increased JBC's discoverability and download rates, even as the IF has declined.

Submit if:

• the paper is rigorous biochemistry with clear mechanistic contribution

• you value fast, constructive peer review from field experts

• the work is strong within biochemistry but doesn't reach Cell/Molecular Cell breadth

• you want the ASBMB community's flagship journal

Think twice if:

• the finding has cross-disciplinary significance (Molecular Cell, EMBO Journal, or Nature)

• the paper is primarily cell biology or genetics without a biochemistry core

• a specialty journal would give better field-specific visibility

A JBC biochemistry depth check can help assess whether the mechanistic evidence package is strong enough for JBC.

ASBMB's current metrics page reports a cited half-life of 18.8 years (checked 19 October 2026). Read this alongside the two-year JIF, rather than treating either measure as the journal's definitive quality score.

The half-life describes the age distribution of papers receiving citations. It does not promise that a new paper will be cited for that many years, measure the lifespan of an individual finding, or establish that JBC has the longest-lasting citations in biology.

For a submission decision, ask whether the journal reaches the researchers who can use and evaluate the contribution. Citation windows can inform that decision, but they cannot replace the scope and evidence checks above.

For a JBC manuscript, three checks follow from ASBMB's current scope and its emphasis on rigorous design, clear alignment between data and conclusions, transparency and reproducibility.

A contribution whose molecular or biochemical value is unclear. State the conceptual advance, mechanistic foundation, or enabling method or resource. A phenotype or correlation needs a clear contribution to that audience, but incomplete mechanistic resolution is not an automatic exclusion under the expanded scope.

Identify what the study establishes and what remains unresolved. If a mechanistic claim depends on a particular experiment, explain that dependency rather than presenting a correlation as its resolution.

An extension without a clear advance. A new substrate, variant or binding partner needs an explanation of what it changes about the underlying understanding or what new research it enables. Technical correctness alone does not explain the contribution's value.

Compare the finding with the closest prior work and identify the decision or hypothesis it changes. Treat this as an editorial judgment to support with evidence, not a prediction based on an estimated acceptance rate.

Conclusions that outrun the design. Separate a demonstrated effect, a proposed explanation and a remaining test. Check whether the controls and analysis support the strongest conclusion, especially when a cellular or organismal result is used to infer a molecular mechanism.

Make the data and analysis inspectable enough for another researcher to evaluate that boundary. These checks apply ASBMB's published priorities; they are not a documented distribution of JBC rejection reasons.